Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
CNY 60.39
(3.51%)
CNY 60.39
(3.51%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.2 Billion CNY | 13.42% |
| 2022 | 3.71 Billion CNY | 22.96% |
| 2021 | 3.01 Billion CNY | 40.53% |
| 2020 | 2.14 Billion CNY | 211.65% |
| 2019 | 689.13 Million CNY | 41.78% |
| 2018 | 486.07 Million CNY | 76.92% |
| 2017 | 274.74 Million CNY | 36.68% |
| 2016 | 201.01 Million CNY | 18.42% |
| 2015 | 169.74 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.97 Billion CNY | -5.28% |
| 2024 Q1 | 4.2 Billion CNY | -0.18% |
| 2024 Q3 | 3.95 Billion CNY | -0.73% |
| 2023 Q4 | 4.2 Billion CNY | 7.51% |
| 2023 FY | 4.2 Billion CNY | 13.42% |
| 2023 Q2 | 3.8 Billion CNY | 1.47% |
| 2023 Q1 | 3.75 Billion CNY | 1.06% |
| 2023 Q3 | 3.91 Billion CNY | 2.88% |
| 2022 Q2 | 3.21 Billion CNY | 3.55% |
| 2022 FY | 3.71 Billion CNY | 22.96% |
| 2022 Q4 | 3.71 Billion CNY | 10.14% |
| 2022 Q3 | 3.36 Billion CNY | 4.88% |
| 2022 Q1 | 3.1 Billion CNY | 2.8% |
| 2021 Q4 | 3.01 Billion CNY | 14.52% |
| 2021 FY | 3.01 Billion CNY | 40.53% |
| 2021 Q3 | 2.63 Billion CNY | 13.15% |
| 2021 Q1 | 2.2 Billion CNY | 2.55% |
| 2021 Q2 | 2.32 Billion CNY | 5.75% |
| 2020 Q2 | 1.89 Billion CNY | 154.46% |
| 2020 Q1 | 743.75 Million CNY | 7.93% |
| 2020 FY | 2.14 Billion CNY | 211.65% |
| 2020 Q3 | 2.09 Billion CNY | 10.69% |
| 2020 Q4 | 2.14 Billion CNY | 2.52% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q4 | 689.13 Million CNY | 0.0% |
| 2019 FY | 689.13 Million CNY | 41.78% |
| 2018 Q3 | 488.11 Million CNY | 0.0% |
| 2018 Q4 | 486.07 Million CNY | -0.42% |
| 2018 FY | 486.07 Million CNY | 76.92% |
| 2017 FY | 274.74 Million CNY | 36.68% |
| 2016 FY | 201.01 Million CNY | 18.42% |
| 2015 FY | 169.74 Million CNY | 0.0% |